CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 8, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	2,013	987	-	-	-	-
Enterprise Value	2,191	1,087	-	-	-	-
Last Close Price	39.65	19.38	-	-	-	-
PE Ratio	36.22	38.65	-	-	-	-
Forward PE	25.16	14.72	-	-	-	-
PS Ratio	4.66	2.50	-	-	-	-
PB Ratio	4.69	2.39	-	-	-	-
P/TBV Ratio	28.85	11.87	-	-	-	-
P/FCF Ratio	35.25	17.94	-	-	-	-
P/OCF Ratio	19.91	10.25	-	-	-	-
PEG Ratio	-	0.82	-	-	-	-
EV/Sales Ratio	5.08	2.76	-	-	-	-
EV/EBITDA Ratio	20.11	11.52	-	-	-	-
EV/EBIT Ratio	24.01	14.15	-	-	-	-
EV/FCF Ratio	38.38	19.77	-	-	-	-
Debt / Equity Ratio	0.63	0.63	1.56	1.40	1.31	4.65
Debt / EBITDA Ratio	2.26	2.66	4.27	5.65	6.21	12.46
Debt / FCF Ratio	4.73	4.75	16.28	9.94	9.81	14.88
Asset Turnover	0.52	0.54	0.49	0.41	0.31	-
Inventory Turnover	1.72	1.92	1.89	1.68	1.42	-
Quick Ratio	1.67	2.07	1.04	1.16	1.14	1.10
Current Ratio	2.51	2.94	1.75	2.00	2.11	2.02
Return on Equity (ROE)	13.72%	9.95%	9.51%	6.31%	-110.67%	-
Return on Assets (ROA)	7.02%	6.52%	5.55%	3.80%	3.48%	-
Return on Capital (ROIC)	8.65%	8.03%	6.85%	4.50%	3.89%	-
Return on Capital Employed (ROCE)	12.50%	10.80%	9.60%	6.60%	7.20%	5.60%
Earnings Yield	2.77%	3.11%	-	-	-	-
FCF Yield	2.84%	5.57%	-	-	-	-
Dividend Yield	0.25%	0.52%	-	-	-	-
Buyback Yield / Dilution	-	-37.23%	60.00%	-	-	-
Total Shareholder Return	0.25%	-36.71%	60.00%	-	-	-

Updated Mar 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.